Non-Hodgkin Lymphoma

Curated

← investigated for

Plerixaforsmall_molecule

unknown

Curated

← investigated for

Pixantrone Dimaleatesmall_molecule

unknown

Curated

← investigated for

Pixantronesmall_molecule

unknown

Curated

← investigated for

Methotrexatesmall_molecule

unknown

Curated

← investigated for

Melphalansmall_molecule

unknown

Curated

← investigated for

Idelalisibsmall_molecule

unknown

Curated

← investigated for

Doxorubicinsmall_molecule

unknown

Curated

← investigated for

Carmustinesmall_molecule

unknown

Curated

← investigated for

Brentuximab Vedotinadc

unknown

Curated

← investigated for

Bendamustinesmall_molecule

unknown

Curated

← investigated for

Zoledronic Acidsmall_molecule

unknown

Curated

← investigated for

Zanubrutinibsmall_molecule

unknown

Curated

← investigated for

Vinorelbinesmall_molecule

unknown

Curated

← investigated for

Vincristinesmall_molecule

unknown

Curated

← investigated for

Tositumomabmonoclonal_antibody

unknown

Curated

← investigated for

Tisagenlecleucelcell_therapy

unknown

Curated

← investigated for

Sirolimussmall_molecule

unknown

Curated

← investigated for

Prednisonesmall_molecule

unknown

Curated

← investigated for

Prednisolonesmall_molecule

unknown

Curated

← investigated for

Polatuzumab Vedotinadc

unknown

Curated

← investigated for

Paclitaxelsmall_molecule

unknown

Curated

← investigated for

Oxaliplatinsmall_molecule

unknown

Curated

← investigated for

Ofatumumabmonoclonal_antibody

unknown

Curated

← investigated for

Obinutuzumabmonoclonal_antibody

unknown

Curated

← investigated for

Mosunetuzumabmonoclonal_antibody

unknown

Curated

← investigated for

Mitoxantronesmall_molecule

unknown

Curated

← investigated for

Lisocabtagene Maraleucelgene_therapy

unknown

Curated

← investigated for

Leucovorinsmall_molecule

unknown

Curated

← investigated for

Lenalidomidesmall_molecule

unknown

Curated

← investigated for

Inotuzumab Ozogamicinadc

unknown

Curated

← investigated for

Ifosfamidesmall_molecule

unknown

Curated

← investigated for

Idarubicinsmall_molecule

unknown

Curated

← investigated for

Ibrutinibsmall_molecule

unknown

Curated

← investigated for

Ibritumomab Tiuxetanmonoclonal_antibody

unknown

Curated

← investigated for

Histaminesmall_molecule

unknown

Curated

← investigated for

Gemcitabinesmall_molecule

unknown

Curated

← investigated for

Fludarabinesmall_molecule

unknown

Curated

← investigated for

Filgrastimother

unknown

Curated

← investigated for

Etoposidesmall_molecule

unknown

Curated

← investigated for

Enzastaurinsmall_molecule

unknown

Curated

← investigated for

Dexamethasonesmall_molecule

unknown

Curated

← investigated for

Daunorubicinsmall_molecule

unknown

Curated

← investigated for

Cytarabinesmall_molecule

unknown

Curated

← investigated for

Cyclophosphamidesmall_molecule

unknown

Curated

← investigated for

Copanlisibsmall_molecule

unknown

Curated

← investigated for

Cisplatinsmall_molecule

unknown

Curated

← investigated for

Carboplatinsmall_molecule

unknown

Curated

← investigated for

Bortezomibsmall_molecule

unknown

Curated

← investigated for

unknown

Curated

← investigated for

Asparaginaseother

unknown

Curated

← investigated for

Vorinostatsmall_molecule

unknown

Curated

← investigated for

Venetoclaxsmall_molecule

unknown

Curated

← investigated for

Treosulfansmall_molecule

unknown

Curated

← investigated for

Topotecansmall_molecule

unknown

Curated

← investigated for

Tislelizumabmonoclonal_antibody

unknown

Curated

← investigated for

Thalidomidesmall_molecule

unknown

Curated

← investigated for

Temsirolimussmall_molecule

unknown

Curated

← investigated for

Temozolomidesmall_molecule

unknown

Curated

← investigated for

Tafasitamabmonoclonal_antibody

unknown

Curated

← investigated for

Pembrolizumabmonoclonal_antibody

unknown

Curated

← investigated for

Pegfilgrastimother

unknown

Curated

← investigated for

Pegargiminaseother

unknown

Curated

← investigated for

Panobinostatsmall_molecule

unknown

Curated

← investigated for

Odronextamabmonoclonal_antibody

unknown

Curated

← investigated for

Nivolumabmonoclonal_antibody

unknown

Curated

← investigated for

Loncastuximab Tesirineadc

unknown

Curated

← investigated for

Lomustinesmall_molecule

unknown

Curated

← investigated for

Irinotecansmall_molecule

unknown

Curated

← investigated for

Imatinib Mesylatesmall_molecule

unknown

Curated

← investigated for

Imatinibsmall_molecule

unknown

Curated

← investigated for

Epirubicinsmall_molecule

unknown

Curated

← investigated for

Epcoritamabmonoclonal_antibody

unknown

Curated

← investigated for

Duvelisibsmall_molecule

unknown

Curated

← investigated for

Durvalumabmonoclonal_antibody

unknown

Curated

← investigated for

Crisantaspaseother

unknown

Curated

← investigated for

Clofarabinesmall_molecule

unknown

Curated

← investigated for

Busulfansmall_molecule

unknown

Curated

← investigated for

Blinatumomabmonoclonal_antibody

unknown

Curated

← investigated for

Bimiralisibsmall_molecule

unknown

Curated

← investigated for

Bevacizumabmonoclonal_antibody

unknown

Curated

← investigated for

Belinostatsmall_molecule

unknown

Curated

← investigated for

Atezolizumabmonoclonal_antibody

unknown

Curated

← investigated for

Aldesleukinother

unknown

Curated

← investigated for

Acalabrutinibsmall_molecule

unknown

Curated

← investigated for

Vindesinesmall_molecule

unknown

Curated

← investigated for

Veliparibsmall_molecule

unknown

Curated

← investigated for

Trastuzumabmonoclonal_antibody

unknown

Curated

← investigated for

Thioguaninesmall_molecule

unknown

Curated

← investigated for

Taselisibsmall_molecule

unknown

Curated

← investigated for

Samotolisibsmall_molecule

unknown

Curated

← investigated for

Ruxolitinibsmall_molecule

unknown

Curated

← investigated for

Romidepsinother

unknown

Curated

← investigated for

Ramucirumabmonoclonal_antibody

unknown

Curated

← investigated for

Pomalidomidesmall_molecule

unknown

Curated

← investigated for

Pictilisibsmall_molecule

unknown

Curated

← investigated for

Pemetrexedsmall_molecule

unknown

Curated

← investigated for

Palbociclibsmall_molecule

unknown

Curated

← investigated for

Niacinamidesmall_molecule

unknown

Curated

← investigated for

Moxetumomab Pasudotoxadc

unknown

Curated

← investigated for

Letrozolesmall_molecule

unknown

Curated

← investigated for

Ipilimumabmonoclonal_antibody

unknown

Curated

← investigated for

Glofitamabmonoclonal_antibody

unknown

Curated

← investigated for

Galiximabmonoclonal_antibody

unknown

Curated

← investigated for

Fulvestrantsmall_molecule

unknown

Curated

← investigated for

Fluorouracilsmall_molecule

unknown

Curated

← investigated for

Everolimussmall_molecule

unknown

Curated

← investigated for

Elimusertibsmall_molecule

unknown

Curated

← investigated for

Dinaciclibsmall_molecule

unknown

Curated

← investigated for

Decitabinesmall_molecule

unknown

Curated

← investigated for

Dasatinibsmall_molecule

unknown

Curated

← investigated for

Daratumumabmonoclonal_antibody

unknown

Curated

← investigated for

Conatumumabmonoclonal_antibody

unknown

Curated

← investigated for

Carfilzomibother

unknown

Curated

← investigated for

Capecitabinesmall_molecule

unknown

Curated

← investigated for

Camrelizumabmonoclonal_antibody

unknown

Curated

← investigated for

Azacitidinesmall_molecule

unknown

Curated

← investigated for

Axicabtagene Ciloleucelgene_therapy

unknown

Curated

← investigated for

Avelumabmonoclonal_antibody

unknown

Curated

← investigated for

Apitolisibsmall_molecule

unknown

Curated

← investigated for

Alemtuzumabmonoclonal_antibody

unknown

Curated

← investigated for

Afliberceptother

unknown

Curated

← investigated for

Abexinostatsmall_molecule

unknown

Curated

← investigated for

Abemaciclibsmall_molecule

unknown

Curated

Peripheral T-Cell Lymphoma, Not Otherwise Specified

Non-Hodgkin Lymphoma altered in cohorts of …ALTERED_INderived15 of 297show all (up to 200)
← altered in cohorts of	PRSS1 42 / 58 cases (72 %) · ssm · RC-PTCL	—	—	Peripheral T-Cell Lymphoma, Not Otherwise Specified	1	Observed	gdc	graph →
← altered in cohorts of	PRSS2 41 / 58 cases (71 %) · ssm · RC-PTCL	—	—	Peripheral T-Cell Lymphoma, Not Otherwise Specified	1	Observed	gdc	graph →
← altered in cohorts of	MTRNR2L6 38 / 58 cases (66 %) · ssm · RC-PTCL	—	—	Peripheral T-Cell Lymphoma, Not Otherwise Specified	1	Observed	gdc	graph →
← altered in cohorts of	IGHV2-70 437 / 961 cases (45 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts	—	—	Multiple Myeloma	2	Observed	gdc	graph →
← altered in cohorts of	DDX3X 124 / 297 cases (42 %) · ssm · mbn_sfu_2023	—	—	B-Cell Non-Hodgkin Lymphoma	1	Observed	cbioportal	graph →
← altered in cohorts of	IGLV3-1 364 / 961 cases (38 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts	—	—	Multiple Myeloma	2	Observed	gdc	graph →
← altered in cohorts of	POTEM 20 / 58 cases (34 %) · ssm · RC-PTCL	—	—	Peripheral T-Cell Lymphoma, Not Otherwise Specified	1	Observed	gdc	graph →
← altered in cohorts of	RHOA 40 / 131 cases (31 %) · ssm · mtnn_msk_2022	—	—	T-Cell Non-Hodgkin Lymphoma	1	Observed	cbioportal	graph →
← altered in cohorts of	SHCBP1 73 / 263 cases (28 %) · ssm · CGCI-BLGSP	—	—	Burkitt Lymphoma	1	Observed	gdc	graph →
← altered in cohorts of	VPS35 67 / 263 cases (25 %) · ssm · CGCI-BLGSP	—	—	Burkitt Lymphoma	1	Observed	gdc	graph →
← altered in cohorts of	ORC6 66 / 263 cases (25 %) · ssm · CGCI-BLGSP	—	—	Burkitt Lymphoma	1	Observed	gdc	graph →
← altered in cohorts of	TPTE 66 / 263 cases (25 %) · ssm · CGCI-BLGSP	—	—	Burkitt Lymphoma	1	Observed	gdc	graph →
← altered in cohorts of	IGHV2-70D 238 / 961 cases (25 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts	—	—	Multiple Myeloma	2	Observed	gdc	graph →
← altered in cohorts of	KMT2D 247 / 1,001 cases (25 %) · ssm · dlbcl_duke_2017 · largest of 6 cohorts	—	—	Diffuse Large B-Cell Lymphoma Unclassifiable	6	Observed	cbioportal	graph →
← altered in cohorts of	KRAS 227 / 961 cases (24 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts	—	—	Multiple Myeloma	2	Observed	gdc	graph →

Non-Hodgkin Lymphoma altered in cohorts of …ALTERED_INderived15 of 297show all (up to 200)

← altered in cohorts of

PRSS1

42 / 58 cases (72 %) · ssm · RC-PTCL

—

Observed

Peripheral T-Cell Lymphoma, Not Otherwise Specified

← altered in cohorts of

PRSS2

41 / 58 cases (71 %) · ssm · RC-PTCL

—

Observed

Peripheral T-Cell Lymphoma, Not Otherwise Specified

← altered in cohorts of

MTRNR2L6

38 / 58 cases (66 %) · ssm · RC-PTCL

—

Observed

← altered in cohorts of

IGHV2-70

437 / 961 cases (45 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts

—

Observed

B-Cell Non-Hodgkin Lymphoma

← altered in cohorts of

DDX3X

124 / 297 cases (42 %) · ssm · mbn_sfu_2023

—

Observed

cbioportal

← altered in cohorts of

IGLV3-1

364 / 961 cases (38 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts

—

Observed

Peripheral T-Cell Lymphoma, Not Otherwise Specified

← altered in cohorts of

POTEM

20 / 58 cases (34 %) · ssm · RC-PTCL

—

Observed

T-Cell Non-Hodgkin Lymphoma

← altered in cohorts of

RHOA

40 / 131 cases (31 %) · ssm · mtnn_msk_2022

—

Observed

cbioportal

← altered in cohorts of

SHCBP1

73 / 263 cases (28 %) · ssm · CGCI-BLGSP

—

Observed

← altered in cohorts of

VPS35

67 / 263 cases (25 %) · ssm · CGCI-BLGSP

—

Observed

← altered in cohorts of

ORC6

66 / 263 cases (25 %) · ssm · CGCI-BLGSP

—

Observed

← altered in cohorts of

TPTE

66 / 263 cases (25 %) · ssm · CGCI-BLGSP

—

Observed

← altered in cohorts of

IGHV2-70D

238 / 961 cases (25 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts

—

Observed

Diffuse Large B-Cell Lymphoma Unclassifiable

← altered in cohorts of

KMT2D

247 / 1,001 cases (25 %) · ssm · dlbcl_duke_2017 · largest of 6 cohorts

—

Observed

cbioportal

← altered in cohorts of

KRAS

227 / 961 cases (24 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts

—

Observed

Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 300show all (up to 200)
→ investigated in trials for	Dexamethasonesmall_molecule 828 trials (260 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	828	Observed	clinicaltrials	graph →
→ investigated in trials for	Rituximabmonoclonal_antibody 633 trials (194 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	633	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall_molecule 598 trials (188 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	598	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenalidomidesmall_molecule 570 trials (202 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	570	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall_molecule 471 trials (101 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	471	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall_molecule 330 trials (90 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	330	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall_molecule 228 trials (32 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	228	Observed	clinicaltrials	graph →
→ investigated in trials for	Daratumumabmonoclonal_antibody 224 trials (121 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	224	Observed	clinicaltrials	graph →
→ investigated in trials for	Pomalidomidesmall_molecule 201 trials (86 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	201	Observed	clinicaltrials	graph →
→ investigated in trials for	Vincristinesmall_molecule 198 trials (71 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	198	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall_molecule 189 trials (68 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	189	Observed	clinicaltrials	graph →
→ investigated in trials for	Prednisonesmall_molecule 189 trials (71 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	189	Observed	clinicaltrials	graph →
→ investigated in trials for	Carfilzomibother 180 trials (67 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	180	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall_molecule 178 trials (45 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	178	Observed	clinicaltrials	graph →
→ investigated in trials for	Ibrutinibsmall_molecule 166 trials (61 active) · roll-up of the cancer and its descendants	—	—	Non-Hodgkin Lymphoma	166	Observed	clinicaltrials	graph →

Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 300show all (up to 200)

→ investigated in trials for

Dexamethasonesmall_molecule

828 trials (260 active) · roll-up of the cancer and its descendants

—

828

Observed

→ investigated in trials for

Rituximabmonoclonal_antibody

633 trials (194 active) · roll-up of the cancer and its descendants

—

633

Observed

→ investigated in trials for

Cyclophosphamidesmall_molecule

598 trials (188 active) · roll-up of the cancer and its descendants

—

598

Observed

→ investigated in trials for

Lenalidomidesmall_molecule

570 trials (202 active) · roll-up of the cancer and its descendants

—

570

Observed

→ investigated in trials for

Bortezomibsmall_molecule

471 trials (101 active) · roll-up of the cancer and its descendants

—

471

Observed

→ investigated in trials for

Fludarabinesmall_molecule

330 trials (90 active) · roll-up of the cancer and its descendants

—

330

Observed

→ investigated in trials for

Melphalansmall_molecule

228 trials (32 active) · roll-up of the cancer and its descendants

—

228

Observed

→ investigated in trials for

Daratumumabmonoclonal_antibody

224 trials (121 active) · roll-up of the cancer and its descendants

—

224

Observed

→ investigated in trials for

Pomalidomidesmall_molecule

201 trials (86 active) · roll-up of the cancer and its descendants

—

201

Observed

→ investigated in trials for

Vincristinesmall_molecule

198 trials (71 active) · roll-up of the cancer and its descendants

—

198

Observed

→ investigated in trials for

Doxorubicinsmall_molecule

189 trials (68 active) · roll-up of the cancer and its descendants

—

189

Observed

→ investigated in trials for

Prednisonesmall_molecule

189 trials (71 active) · roll-up of the cancer and its descendants

—

189

Observed

→ investigated in trials for

Carfilzomibother

180 trials (67 active) · roll-up of the cancer and its descendants

—

180

Observed

→ investigated in trials for

Etoposidesmall_molecule

178 trials (45 active) · roll-up of the cancer and its descendants

—

178

Observed

→ investigated in trials for

Ibrutinibsmall_molecule

166 trials (61 active) · roll-up of the cancer and its descendants

—

166

Observed

Primary Effusion Lymphoma

Non-Hodgkin Lymphoma studied in …STUDIED_INderived10 of 7,580show all (up to 200)
→ studied in	NCT00006518recruiting Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)	—	—	Primary Effusion Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00923507recruiting Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)	—	—	Waldenstrom Macroglobulinemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT01087294Phase 1 · completed Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 7,580 trials mapped (2,362 active)	—	—	Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01676805recruiting Tissue Collection for Studies of Lymph Cancer · condition mapped ALIAS · 7,580 trials mapped (2,362 active)	—	—	Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02180711Phase 1/Phase 2 · active not recruiting Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)	—	—	Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02473757enrolling by invitation Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies · condition mapped CURATED_EXACT · 7,580 trials mapped (2,362 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02682667recruiting Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols · condition mapped ALIAS · 7,580 trials mapped (2,362 active)	—	—	Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03223610Phase 1/Phase 2 · recruiting Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)	—	—	Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03412877Phase 2 · recruiting Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer · condition mapped CURATED_EXACT · 7,580 trials mapped (2,362 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03418038Phase 2 · recruiting Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)	—	—	High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements	1	Observed	clinicaltrials	graph →

Non-Hodgkin Lymphoma studied in …STUDIED_INderived10 of 7,580show all (up to 200)

→ studied in

NCT00006518recruiting

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)

—

Observed

Waldenstrom Macroglobulinemia

→ studied in

NCT00923507recruiting

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)

—

Observed

→ studied in

NCT01087294Phase 1 · completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 7,580 trials mapped (2,362 active)

—

Observed

→ studied in

NCT01676805recruiting

Tissue Collection for Studies of Lymph Cancer · condition mapped ALIAS · 7,580 trials mapped (2,362 active)

—

Observed

→ studied in

NCT02180711Phase 1/Phase 2 · active not recruiting

Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)

—

Observed

→ studied in

NCT02473757enrolling by invitation

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies · condition mapped CURATED_EXACT · 7,580 trials mapped (2,362 active)

—

Observed

→ studied in

NCT02682667recruiting

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols · condition mapped ALIAS · 7,580 trials mapped (2,362 active)

—

Observed

→ studied in

NCT03223610Phase 1/Phase 2 · recruiting

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)

—

Observed

→ studied in

NCT03412877Phase 2 · recruiting

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer · condition mapped CURATED_EXACT · 7,580 trials mapped (2,362 active)

—

Observed

High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements

→ studied in

NCT03418038Phase 2 · recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 7,580 trials mapped (2,362 active)

—

Observed